Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens

Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens

US Patent 9028840 · Granted May 12, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Epstein-Barr virus-like particles with broadened antigenic spectrum2023
Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing2022
Tissue-specific exosomes as biomarkers2021
EBV vaccine2021
B-cell receptor complex binding proteins containing T-cell epitopes2021
B-cell receptor complex binding proteins containing T-cell epitopes2021
B-cell receptor complex binding proteins containing T-cell epitopes2018
B-cell receptor complex binding proteins containing T-cell epitopes2018
Second generation virus-like particles (VLP) from Epstein-Barr viruses for vacci2016
Second generation virus-like particles (VLP) from Epstein-Barr viruses for vacci2016
Method of identifying CD4+ T cell antigens2016
Method of identifying CD4+ T cell antigens2016